Feasibility of TCI etomidate for total intravenous anesthesia
- VernacularTitle:靶控输注依托咪酯用于全身麻醉维持的可行性研究
- Author:
Ji LIU
;
Jinbao LI
;
Xiaoming DENG
- Publication Type:Journal Article
- Keywords:
Etomidate;
Propofol;
Cortisol;
Aldosterone;
ACTH
- From:
The Journal of Clinical Anesthesiology
2009;25(5):389-391
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the feasibility of TCI etomidate for total intravenous anesthesia (TIVA). Methods Forty patients scheduled for abdominal operation were divided into two groups with 20 cases each. Anesthesia in group E was induced and maintained with TCI etomidate 1-2 μg/ml and remifentanil 6 ng/ml,which in group P with TCI propofol 2-4 μg/ml and remifentanil 6 ng/ml to keep BIS 40-60. The perioperative changes of plasma glucose, cortisol, aldosterone and ACTH were Observed. Recovery from anethesia was recorded as well Results Both groups had the stabilized hemodynamics and glucose concentration. The plasma cortisol and ACTH concentrations in group E were decreased at the end of operation(P<0.05), but returned to preoperative level on the next day, which were not significantly changed perioperatively in group P. The time of eye opening was longer in group E than that in group P. Conclusion Etomidate has an inhibition on the function of the adrenal cortex temporally and can be used safely togather with remifentanil for TIVA in patients without hypoadrenocorticism.
